IDH2 Antibodies

Santa Cruz Biotechnology provides a broad selection of IDH2 monoclonal antibodies for research focused on understanding isocitrate dehydrogenase 2 (IDH2) in cellular metabolism and disease. IDH2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IDH2 is a critical enzyme in the tricarboxylic acid (TCA) cycle, playing a vital role in cellular energy production and metabolic regulation. Mutations in the IDH2 gene have been implicated in several types of cancer, making it an important target for therapeutic intervention and biomarker discovery. Understanding IDH2 function can provide insights into metabolic reprogramming in cancer and other diseases. Researchers worldwide rely on IDH2 monoclonal antibodies to advance their studies in cellular metabolism. IDH2 monoclonal antibodies enable detailed investigation of metabolic pathways and their regulation in various biological systems. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to understanding cellular metabolism and disease mechanisms.